A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis

A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis

BackgroundAzelastine hydrochloride (AZE) is a selective, non-sedating H1 antagonist with anti-inflammatory and mast cell stabilizing properties, which can be used as an alternative to intranasal corticosteroids. The objective of this study was to evaluate the efficacy of the new formulation of 0.15%...

Full description

Bibliographic Details
Main Authors: Jean Bousquet, Ludger Klimek, Hans-Christian Kuhl, Duc Tung Nguyen, Rajesh Kumar Ramalingam, G. W. Canonica, William E. Berger
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Allergy
Subjects:
perennial allergic rhinitis
azelastine hydrochloride
intranasal antihistamines
allergic rhinitis
randomized clinical trial
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2023.1244012/full

Similar Items

Similar Items